bpc-157 human trials safety An FDA advisory panel narrowly voted to ease restrictions on injectable “wellness” peptides like and TB-500, despite FDA scientists warning there's little evidence they're safe or effective. If the FDA follows Is BPC-157 safe for use

Maintain goal BP for 12 days, and further reduce BP toward normal over several weeks

Initial Treatment in Combination with Pembrolizumab and Platinum The efficacy of pemetrexed in combination with pembrolizumab and platinum chemotherapy was investigated in Study KEYNOTE-189 (NCT02578680), a randomized, multicenter, double-blind, active-controlled trial conducted in patients with metastatic non-squamous NSCLC, regardless of PD-L1 tumor expression status, who had not previously received systemic therapy for metastatic disease and in whom there were no EGFR or ALK genomic tumor aberrations

He also notes that there is almost zero human data on this peptide

- **60mg** -- Best value for higher-dose users (8-12mg)